GLTO logo

GLTOGalecto Inc

$20.92
$0.77
(3.82%)
Today
Updated: 11:17 AM EDT
Reported EarningsMay 12
Mkt Cap$1.24B
Vol91,058.00
39

Bearish Sentiment

How do you feel about GLTO?

About

Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

What is Market Cap of Damora Therapeutics Inc.?
What is the 52-week high for Damora Therapeutics Inc.?
What is the 52-week low for Damora Therapeutics Inc.?
What is Damora Therapeutics Inc. stock price today?
What was Damora Therapeutics Inc. stock price yesterday?
What is the PE ratio of Damora Therapeutics Inc.?
What is the Price-to-Book ratio of Damora Therapeutics Inc.?
What is the 50-day moving average of Damora Therapeutics Inc.?
How many employees does Damora Therapeutics Inc. have?

Advertisement|Remove ads.